Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
N Engl J Med
.
2018 Feb 1;378(5):485-486.
doi: 10.1056/NEJMc1715183.
Authors
Christopher P Cannon
1
,
Gregory Y H Lip
2
,
Jonas Oldgren
3
Affiliations
1
Baim Institute for Clinical Research, Boston, MA christopher.cannon@baiminstitute.org
2
University of Birmingham, Birmingham, United Kingdom
3
Uppsala University, Uppsala, Sweden
PMID:
29385366
DOI:
10.1056/NEJMc1715183
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants
Atrial Fibrillation*
Dabigatran*
Fibrinolytic Agents
Humans
Percutaneous Coronary Intervention
Stroke
Warfarin
Substances
Anticoagulants
Fibrinolytic Agents
Warfarin
Dabigatran